CS logo
small CS logo
Hospital de Sagunto

Sagunto, Valencia, Spain
Hospital in the Port de Sagunt
Av. Ramón Y Cajal, s/n, 46520 Port de Sagunt, Valencia

About Hospital de Sagunto


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
PETHEMA Foundation
6
Spanish Breast Cancer Research Group
5
Tigenix S.A.U.
4
Hospital Arnau de Vilanova
3
Chinook Therapeutics U.S., Inc.
2
Galapagos NV
2
Grupo Espanol Multidisciplinario del Cancer Digestivo
2
Kowa Research Europe
2
Merz Pharmaceuticals GmbH
2
Spanish Lung Cancer Group
2
Takeda
2
Total Rows: 29

Clinical Trials at Hospital de Sagunto


During the past decade, Hospital de Sagunto conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 4 clinical trials were completed, i.e. on average, 23.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11333311222233220000111111001100Started TrialsCompleted Trails2015201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
1999-03-01
2007-04-01
Completed
Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer
1999-11-01
2007-12-01
Completed
1,289
Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis
2005-04-08
2009-09-07
Completed
829
Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin
2005-09-01
2006-10-01
Completed
355
Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
2006-07-01
2007-11-01
Completed
1,355
Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours
2006-05-01
2009-11-01
Completed
30
GEM05 for Patients With Multiple Myeloma More Than 65 Years Old
2005-03-01
2009-12-01
Completed
260
GEM05 for Patients With Multiple Myeloma Under 65 Years
2006-03-01
2008-12-01
Completed
390

Rows per page:

1–50 of 50

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Hospital de Sagunto" #1 sponsor was "PETHEMA Foundation" with 6 trials, followed by "Spanish Breast Cancer Research Group" with 5 trials sponsored, "Tigenix S.A.U." with 4 trials sponsored, "Hospital Arnau de Vilanova" with 3 trials sponsored and "Chinook Therapeutics U.S., Inc." with 3 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 29 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Sagunto" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "Roche Farma, S.A" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPETHEMA Foundation: 6PETHEMA Foundation: 6Spanish Breast CancerResearch Group: 5Spanish Breast CancerResearch Group: 5Tigenix S.A.U.: 4Tigenix S.A.U.: 4Hospital Arnau de Vilanova: 3Hospital Arnau de Vilanova: 3Chinook TherapeuticsU.S., Inc.: 2Chinook TherapeuticsU.S., Inc.: 2Galapagos NV: 2Galapagos NV: 2Grupo EspanolMultidisciplinario delCancer Digestivo: 2Grupo EspanolMultidisciplinario delCancer Digestivo: 2Kowa Research Europe: 2Kowa Research Europe: 2Merz Pharmaceuticals GmbH: 2Merz Pharmaceuticals GmbH: 2Spanish Lung Cancer Group: 2Spanish Lung Cancer Group: 2

Created with Highcharts 11.1.0Top CollaboratorsAstraZeneca: 2AstraZeneca: 2Gilead Sciences: 2Gilead Sciences: 2Hoffmann-La Roche: 2Hoffmann-La Roche: 2Pfizer: 2Pfizer: 2Roche Farma, S.A: 2Roche Farma, S.A: 2AECC_AsociaciónEspañola contra elCáncer: 1AECC_AsociaciónEspañola contra elCáncer: 1Biopolis S.L.: 1Biopolis S.L.: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Celgene: 1Celgene: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1

Clinical Trials Conditions at Hospital de Sagunto


According to Clinical.Site data, the most researched conditions in "Hospital de Sagunto" are "Crohn's Disease" (4 trials), "Breast Cancer" (3 trials), "IgA Nephropathy" (3 trials), "Acute Lymphoblastic Leukemia" (2 trials) and "Carcinoma, Non-Small-Cell Lung" (2 trials). Many other conditions were trialed in "Hospital de Sagunto" in a lesser frequency.

Clinical Trials Intervention Types at Hospital de Sagunto


Most popular intervention types in "Hospital de Sagunto" are "Drug" (35 trials), "Other" (8 trials), "Procedure" (5 trials), "Biological" (3 trials) and "Dietary Supplement" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Cyclophosphamide" (3 trials), "Atrasentan" (2 trials), "Cx601" (2 trials) and "Daunorubicin" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Hospital de Sagunto


The vast majority of trials in "Hospital de Sagunto" are 44 trials for "All" genders and 6 trials for "Female" genders.

Clinical Trials Status at Hospital de Sagunto


Currently, there are NaN active trials in "Hospital de Sagunto". undefined are not yet recruiting, 8 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 26 completed trials in Hospital de Sagunto, undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital de Sagunto, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 5 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 21Phase 3: 21Phase 2: 8Phase 2: 8Not Applicable: 5Not Applicable: 5Phase 4: 5Phase 4: 5

Created with Highcharts 11.1.0Trials StatusCompleted: 26Completed: 26Recruiting: 8Recruiting: 8Unknown status: 6Unknown status: 6Active, not recruiting: 4Active, not recruiting: 4Terminated: 4Terminated: 4Available: 1Available: 1Enrolling by invitation: 1Enrolling by invitation: 1